Krensavage Asset Management, LLC Long-Term Concentrated

Location: New York, NY

CIK: 0001609251 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 13, 2015

Total Value: $265M (100.0% shares, 0.0% debt)

Holdings (22)

ENTA ENANTA PHARMACEUTICALS INC 12.0%
Value $31.8M Shares 706,908 Est. Cost $38.91 Unrealized -0.0%
UTHR UNITED THERAPEUTICS CORP 9.8%
Value $25.89M Shares 148,858 Est. Cost $136.01 Unrealized +32.3%
IMPAX LABORATORIES INC 7.9%
Value $20.91M Shares 455,475 Est. Cost $33.07 Unrealized
TEVA TEVA PHARMACEUTICAL-SP ADR 6.9%
Value $18.32M Shares 309,962 Est. Cost $58.27 Unrealized
HALYARD HEALTH INC 6.7%
Value $17.67M Shares 436,243 Est. Cost $44.28 Unrealized
OM2 ORTHOFIX INTERNATIONAL NV 6.5%
Value $17.34M Shares 523,447 Est. Cost $31.31 Unrealized
SUCAMPO PHARMACEUTICALS-CL A 6.0%
Value $15.89M Shares 967,404 Est. Cost $14.35 Unrealized
CNMD CONMED CORP 5.8%
Value $15.47M Shares 265,428 Est. Cost $37.45 Unrealized +27.7%
INDIVIOR PLC 5.8%
Value $15.26M Shares 4,318,944 Est. Cost $3.37 Unrealized
MRK MERCK & CO. INC. 4.8%
Value $12.64M Shares 222,103 Est. Cost $39.42 Unrealized +2.1%
RTI SURGICAL INC 4.3%
Value $11.44M Shares 1,770,072 Est. Cost $5.24 Unrealized
HILL-ROM HOLDINGS INC 4.1%
Value $10.82M Shares 199,113 Est. Cost $46.09 Unrealized
AMGEN INC 4.0%
Value $10.61M Shares 69,086 Est. Cost $158.50 Unrealized
DEPOMED INC 2.9%
Value $7.788M Shares 362,887 Est. Cost $16.40 Unrealized
INVACARE CORP 2.9%
Value $7.649M Shares 353,632 Est. Cost $17.02 Unrealized
ALLERGAN PLC 2.7%
Value $7.068M Shares 23,290 Est. Cost $303.48 Unrealized
SPECTRUM PHARMACEUTICALS INC 2.2%
Value $5.771M Shares 843,702 Est. Cost $6.84 Unrealized
BIOTA PHARMACEUTICALS INC 1.3%
Value $3.392M Shares 1,638,492 Est. Cost $2.22 Unrealized
THERAVANCE INC 1.2%
Value $3.077M Shares 170,308 Est. Cost $14.36 Unrealized
JUNIPER PHARMACEUTICALS INC 1.1%
Value $2.998M Shares 327,617 Est. Cost $9.15 Unrealized
DIGIRAD CORP 0.7%
Value $1.923M Shares 443,099 Est. Cost $4.36 Unrealized
FURIEX PHARMACEUTICA CMN 0.5%
Value $1.422M Shares 145,544 Est. Cost $9.77 Unrealized